Avancès C - Search Results

1

Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.

Culine S, Iborra F, Mottet N, Avancès C, de Graeve B, Volpé P, Vignoud J, Bringer JP, Marroncle M, Le Pellec L, Ayuso D, Jansen E, Faix A, Rebillard X. Culine S, et al. Among authors: avances c. Am J Clin Oncol. 2006 Apr;29(2):148-52. doi: 10.1097/01.coc.0000203753.74851.d5. Am J Clin Oncol. 2006. PMID: 16601433 Clinical Trial.

2

[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?].

El Demery M, Pouessel D, Avancès C, Iborra F, Rebillard X, Faix A, Ségui B, Delbos O, Ayuso D, Culine S. El Demery M, et al. Among authors: avances c. Prog Urol. 2006 Jun;16(3):320-3. Prog Urol. 2006. PMID: 16821344 French.

3

Liver metastases in prostate carcinoma: clinical characteristics and outcome.

Pouessel D, Gallet B, Bibeau F, Avancès C, Iborra F, Sénesse P, Culine S. Pouessel D, et al. Among authors: avances c. BJU Int. 2007 Apr;99(4):807-11. doi: 10.1111/j.1464-410X.2006.06663.x. Epub 2006 Nov 28. BJU Int. 2007. PMID: 17155968

4

Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.

Culine S, El Demery M, Lamy PJ, Iborra F, Avancès C, Pinguet F. Culine S, et al. Among authors: avances c. J Urol. 2007 Sep;178(3 Pt 1):844-8; discussion 848. doi: 10.1016/j.juro.2007.05.044. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631339 Clinical Trial.

5

Prognostic factors for first recurrence in patients with retroperitoneal sarcoma.

Avancès C, Mottet N, Mahatmat A, Chapuis E, Serre I, Culine S. Avancès C, et al. Urol Oncol. 2006 Mar-Apr;24(2):94-6. doi: 10.1016/j.urolonc.2005.09.004. Urol Oncol. 2006. PMID: 16520270

6

Prompt resolution of acute disseminated intravascular coagulation with docetaxel and cisplatin in hormone refractory prostate cancer.

Avancès C, Jacot W, Sénesse P, Culine S. Avancès C, et al. J Urol. 2002 Oct;168(4 Pt 1):1496. doi: 10.1016/S0022-5347(05)64487-4. J Urol. 2002. PMID: 12352431 No abstract available.

7

[Recommendations Onco-Urology 2010: Malignancies of the penis].

Rigaud J, Avancès C, Camparo P, Culine S, Durand X, Iborra F, Mottet N, Sèbe P, Soulié M; Oncology Committee of the French Association of Urology (CCAFU). Rigaud J, et al. Among authors: avances c. Prog Urol. 2010 Nov;20 Suppl 4:S279-89. doi: 10.1016/S1166-7087(10)70044-0. Prog Urol. 2010. PMID: 21129646 French. No abstract available.

8

[What about lombo-aortic curage in the treatment of testicle cancer?].

Iborra F, Avances C, Culine S, Houlgatte A, Mottete N. Iborra F, et al. Among authors: avances c. Ann Urol (Paris). 2007 Jun;41(3):116-26. doi: 10.1016/j.anuro.2007.04.002. Ann Urol (Paris). 2007. PMID: 18260272 Review. French.

9

[Long-term morbidity of living donor kidney harvesting].

Gres P, Avances C, Iborra F, Mourad G, Guiter J. Gres P, et al. Among authors: avances c. Prog Urol. 2007 Apr;17(2):194-8. doi: 10.1016/s1166-7087(07)92262-9. Prog Urol. 2007. PMID: 17489317 French.

10

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S, Fajas L. Clapé C, et al. Among authors: avances c. PLoS One. 2009 Oct 26;4(10):e7542. doi: 10.1371/journal.pone.0007542. PLoS One. 2009. PMID: 19855844 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters